phospho ser cdk1 substrate Search Results


92
Sino Biological histone h1
Decrease in phosphate in <t>phosphoramidate</t> <t>phosphorylated</t> histone <t>H1</t> (▪) and 30 kDa polylysine (⧫) during incubation with PHPT1. The concentration was 1 mg/mL of phosphohistone and 2 mg/mL of phosphopolylysine. An amount of 5 pmol PHPT1 was added per 51 µL incubation volume. The reaction was performed at pH 7.5 and 30°C during indicated times and was interrupted by centrifugation of 50 µL of the reaction mixture through a spin column containing 200 µL of DEAE-Sepharose equilibrated in 25 mM Tris/HCl pH 8.5. The protein-bound, acid-labile phosphate in the final eluate was analyzed as described under Methods. Each time point was analyzed in duplicate.
Histone H1, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/histone h1/product/Sino Biological
Average 92 stars, based on 1 article reviews
histone h1 - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc primary 426 antibodies to cdk1
Fig. 5. NSs interacts with <t>CDK1</t> and inhibits the cyclin B1-CDK1 complex from 744
Primary 426 Antibodies To Cdk1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary 426 antibodies to cdk1/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
primary 426 antibodies to cdk1 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc phospho ser cdk1 substrate cell signaling tech cell signaling tech 9477
Fig. 5. NSs interacts with <t>CDK1</t> and inhibits the cyclin B1-CDK1 complex from 744
Phospho Ser Cdk1 Substrate Cell Signaling Tech Cell Signaling Tech 9477, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho ser cdk1 substrate cell signaling tech cell signaling tech 9477/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
phospho ser cdk1 substrate cell signaling tech cell signaling tech 9477 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc anti cdk1
Fig. 5. NSs interacts with <t>CDK1</t> and inhibits the cyclin B1-CDK1 complex from 744
Anti Cdk1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cdk1/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
anti cdk1 - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc anti cdk1 substrate antibodies
A, B. HeLa cells expressing GFP-CHMP7 δHelix6 were imaged live (A) and the intensity of GFP-CHMP7 δHelix6 puncta was quantified during M-phase (B). Quantification of 59 cells from 9 experiments. Fluorescence traces normalised to metaphase onset (open arrowhead); nuclear envelope breakdown indicated by closed arrowhead. C. Lysates of HeLa cells stably expressing GFP-CHMP7 and subject to the indicated synchronisations were immunoprecipitated using GFP-trap resin and resolved using normal or PhosTag SDS-PAGE. Inputs and captured fractions were examined by western blotting with antisera raised against GFP, or <t>CDK1</t> substrate consensus sequences ([K/H]-[pS]-[P] or [pS]-[P]-[X]-[R/K]). Western blots representative of 6 PhosTag immunoprecipitations. D. Lysates of HeLa cells stably expressing GFP-CHMP7 or GFP-CHMP7 S3A, S441A and subject to the indicated synchronisations were immunoprecipitated using GFP-trap resin and resolved using normal or PhosTag SDS-PAGE. Inputs and captured fractions were examined by western blotting with antisera raised against GFP, Histone H3 pSer10 or GAPDH (N = 3).
Anti Cdk1 Substrate Antibodies, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cdk1 substrate antibodies/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
anti cdk1 substrate antibodies - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

90
Cell Signaling Technology Inc phospho-cdk1 substrates, pcdk substrates
A, B. HeLa cells expressing GFP-CHMP7 δHelix6 were imaged live (A) and the intensity of GFP-CHMP7 δHelix6 puncta was quantified during M-phase (B). Quantification of 59 cells from 9 experiments. Fluorescence traces normalised to metaphase onset (open arrowhead); nuclear envelope breakdown indicated by closed arrowhead. C. Lysates of HeLa cells stably expressing GFP-CHMP7 and subject to the indicated synchronisations were immunoprecipitated using GFP-trap resin and resolved using normal or PhosTag SDS-PAGE. Inputs and captured fractions were examined by western blotting with antisera raised against GFP, or <t>CDK1</t> substrate consensus sequences ([K/H]-[pS]-[P] or [pS]-[P]-[X]-[R/K]). Western blots representative of 6 PhosTag immunoprecipitations. D. Lysates of HeLa cells stably expressing GFP-CHMP7 or GFP-CHMP7 S3A, S441A and subject to the indicated synchronisations were immunoprecipitated using GFP-trap resin and resolved using normal or PhosTag SDS-PAGE. Inputs and captured fractions were examined by western blotting with antisera raised against GFP, Histone H3 pSer10 or GAPDH (N = 3).
Phospho Cdk1 Substrates, Pcdk Substrates, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho-cdk1 substrates, pcdk substrates/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
phospho-cdk1 substrates, pcdk substrates - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc rabbit anti phospho cdk1 y15p
A, B. HeLa cells expressing GFP-CHMP7 δHelix6 were imaged live (A) and the intensity of GFP-CHMP7 δHelix6 puncta was quantified during M-phase (B). Quantification of 59 cells from 9 experiments. Fluorescence traces normalised to metaphase onset (open arrowhead); nuclear envelope breakdown indicated by closed arrowhead. C. Lysates of HeLa cells stably expressing GFP-CHMP7 and subject to the indicated synchronisations were immunoprecipitated using GFP-trap resin and resolved using normal or PhosTag SDS-PAGE. Inputs and captured fractions were examined by western blotting with antisera raised against GFP, or <t>CDK1</t> substrate consensus sequences ([K/H]-[pS]-[P] or [pS]-[P]-[X]-[R/K]). Western blots representative of 6 PhosTag immunoprecipitations. D. Lysates of HeLa cells stably expressing GFP-CHMP7 or GFP-CHMP7 S3A, S441A and subject to the indicated synchronisations were immunoprecipitated using GFP-trap resin and resolved using normal or PhosTag SDS-PAGE. Inputs and captured fractions were examined by western blotting with antisera raised against GFP, Histone H3 pSer10 or GAPDH (N = 3).
Rabbit Anti Phospho Cdk1 Y15p, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti phospho cdk1 y15p/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
rabbit anti phospho cdk1 y15p - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

90
Millipore phospho-cdk1 substrate antibody
A, B. HeLa cells expressing GFP-CHMP7 δHelix6 were imaged live (A) and the intensity of GFP-CHMP7 δHelix6 puncta was quantified during M-phase (B). Quantification of 59 cells from 9 experiments. Fluorescence traces normalised to metaphase onset (open arrowhead); nuclear envelope breakdown indicated by closed arrowhead. C. Lysates of HeLa cells stably expressing GFP-CHMP7 and subject to the indicated synchronisations were immunoprecipitated using GFP-trap resin and resolved using normal or PhosTag SDS-PAGE. Inputs and captured fractions were examined by western blotting with antisera raised against GFP, or <t>CDK1</t> substrate consensus sequences ([K/H]-[pS]-[P] or [pS]-[P]-[X]-[R/K]). Western blots representative of 6 PhosTag immunoprecipitations. D. Lysates of HeLa cells stably expressing GFP-CHMP7 or GFP-CHMP7 S3A, S441A and subject to the indicated synchronisations were immunoprecipitated using GFP-trap resin and resolved using normal or PhosTag SDS-PAGE. Inputs and captured fractions were examined by western blotting with antisera raised against GFP, Histone H3 pSer10 or GAPDH (N = 3).
Phospho Cdk1 Substrate Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho-cdk1 substrate antibody/product/Millipore
Average 90 stars, based on 1 article reviews
phospho-cdk1 substrate antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc phospho cdk1 substrate consensus sequence
A FMNL1 schematic ( B ) MSMS scan of residues 1024–1034 (1 experiment). C Representative GFP-FMNL1 IP from cells treated with vehicle ( ~ 2 h DMSO) or adavosertib ( ~ 6.5 h 300 nM). Probed with anti-GFP and <t>anti-phoso-CDK1</t> substrate sequence. Repeated 3X. D Effects of ~4 h adavosertib at 300 nM on wave. Unequal contrasting between groups for ease of viewing. E Effects of CDK1 inhibitors on wave. Asterisk denotes contrast adjustment between conditions, performed as acquisition parameters varied throughout experiment. F CDK1 siRNA treatment. G Effects of adavosertib on wave speed; bars represent means with SEM. Two-sided Student’s t-test. N = 20 and 23 cells across 4 experiments for DMSO and Wee1 inhibitor, respectively. H Effects of CDK1 inhibitors on wave area. CDK1 inhibitors tested in a larger screen; DMSO data run in parallel previously published in Extended figure 8 A of ref. . Analyzed by Kruskal-Wallis test with Dunn’s multiple comparisons was run. n = 151 and 212 cells across 3 experiments for Ro3306 and CGP74 conditions, respectively. I Effects of CDK1 knockdown on wave area. Kruskal-Wallis test with Dunn’s multiple comparisons. n = 60 cells across 3 experiments. J CDK1 knockdown (see Figure ). Means from 3 experiments. K Effects of GFP-FMNL1 WT and S1031A on wave; staining TOMM20 and phalloidin. GFP signal for ‘GFP alone’ condition was differentially scaled. L Wave areas analyzed by Kruskal-Wallis test, Dunn’s multiple comparisons; 40 cells across 4 experiments. M Western blot of GFP-FMNL1 WT and S1031A. N Mean fluorescence: GFP-FMNL1 WT/S1031A. Bars indicate means of triangles, which represent means of 4 biological replicates. O Effects of S1031E on wave; staining for TOMM20 and phalloidin. P Effects on wave area; two-sided Mann-Whitney test, 60 cells across 3 experiments. Q Western of GFP-FMNL1 S1031E. R Mean fluorescence: GFP-FMNL1 WT/S1031E. A – R Scale bars: 10 μm for cell images, 2 μm for insets. For blots, antibody/total protein approximately aligned/scaled the same; kDa, unit of molecular weight. Box plots: center lines indicate medians, plus signs indicate means, error bars = 10–90th percentile. Source data provided. *, **, and *** indicate p -values of < 0.05, ≤ 0.005, and ≤ 0.0005 respectively.
Phospho Cdk1 Substrate Consensus Sequence, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho cdk1 substrate consensus sequence/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
phospho cdk1 substrate consensus sequence - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc anti cdk1 phosphorylated substrates
A FMNL1 schematic ( B ) MSMS scan of residues 1024–1034 (1 experiment). C Representative GFP-FMNL1 IP from cells treated with vehicle ( ~ 2 h DMSO) or adavosertib ( ~ 6.5 h 300 nM). Probed with anti-GFP and <t>anti-phoso-CDK1</t> substrate sequence. Repeated 3X. D Effects of ~4 h adavosertib at 300 nM on wave. Unequal contrasting between groups for ease of viewing. E Effects of CDK1 inhibitors on wave. Asterisk denotes contrast adjustment between conditions, performed as acquisition parameters varied throughout experiment. F CDK1 siRNA treatment. G Effects of adavosertib on wave speed; bars represent means with SEM. Two-sided Student’s t-test. N = 20 and 23 cells across 4 experiments for DMSO and Wee1 inhibitor, respectively. H Effects of CDK1 inhibitors on wave area. CDK1 inhibitors tested in a larger screen; DMSO data run in parallel previously published in Extended figure 8 A of ref. . Analyzed by Kruskal-Wallis test with Dunn’s multiple comparisons was run. n = 151 and 212 cells across 3 experiments for Ro3306 and CGP74 conditions, respectively. I Effects of CDK1 knockdown on wave area. Kruskal-Wallis test with Dunn’s multiple comparisons. n = 60 cells across 3 experiments. J CDK1 knockdown (see Figure ). Means from 3 experiments. K Effects of GFP-FMNL1 WT and S1031A on wave; staining TOMM20 and phalloidin. GFP signal for ‘GFP alone’ condition was differentially scaled. L Wave areas analyzed by Kruskal-Wallis test, Dunn’s multiple comparisons; 40 cells across 4 experiments. M Western blot of GFP-FMNL1 WT and S1031A. N Mean fluorescence: GFP-FMNL1 WT/S1031A. Bars indicate means of triangles, which represent means of 4 biological replicates. O Effects of S1031E on wave; staining for TOMM20 and phalloidin. P Effects on wave area; two-sided Mann-Whitney test, 60 cells across 3 experiments. Q Western of GFP-FMNL1 S1031E. R Mean fluorescence: GFP-FMNL1 WT/S1031E. A – R Scale bars: 10 μm for cell images, 2 μm for insets. For blots, antibody/total protein approximately aligned/scaled the same; kDa, unit of molecular weight. Box plots: center lines indicate medians, plus signs indicate means, error bars = 10–90th percentile. Source data provided. *, **, and *** indicate p -values of < 0.05, ≤ 0.005, and ≤ 0.0005 respectively.
Anti Cdk1 Phosphorylated Substrates, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cdk1 phosphorylated substrates/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
anti cdk1 phosphorylated substrates - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc ser780 antibody htscan cdk1 cycb kinase assay kit
Confocal sections from retinas of E6 chick embryos were double labeled with the <t>anti-cdk1</t> specific mAbs (red) (B-6) ( A ), [A17] ( B ), and (17) ( C - E ), as well as with anti-p75 NTR (p75) ( C ), anti-phosphoHistone H3 (pH3) ( D ), or anti-TrkB ( E ) antibodies (green). Nuclear staining with bisbenzimide is shown in blue (Bisb.). ( A , B ) Cdk1 immunostaining is observed in the cytoplasm of a subpopulation of retinal cells and often in nuclei located apically (arrows). ( C ) A subset of cdk1-positive cells co-localize with p75 NTR (arrowhead), whereas many other p75 NTR -positive cells lack cdk1 immunolabeling (arrow). ( D ) Cdk1-positive cells co-localize with phosphoHistone H3 in the basal retina, close to the presumptive GCL (arrow). Arrowhead: apically located nucleus with cdk1-specific immunoreactivity. ( E ) TrkB-positive cells co-localize with cdk1 (arrow). Boxes: high magnification of the dashed areas. GCL: ganglion cell layer; PE: pigment epithelium; v: vitreous body. Bar: 20 µm ( A - D ), 40 µm ( E ).
Ser780 Antibody Htscan Cdk1 Cycb Kinase Assay Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ser780 antibody htscan cdk1 cycb kinase assay kit/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
ser780 antibody htscan cdk1 cycb kinase assay kit - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc 3377s ab 1549594 phospho chk1 ser345 cell signaling technology 2348l ab 331212 phospho cdc2
Confocal sections from retinas of E6 chick embryos were double labeled with the <t>anti-cdk1</t> specific mAbs (red) (B-6) ( A ), [A17] ( B ), and (17) ( C - E ), as well as with anti-p75 NTR (p75) ( C ), anti-phosphoHistone H3 (pH3) ( D ), or anti-TrkB ( E ) antibodies (green). Nuclear staining with bisbenzimide is shown in blue (Bisb.). ( A , B ) Cdk1 immunostaining is observed in the cytoplasm of a subpopulation of retinal cells and often in nuclei located apically (arrows). ( C ) A subset of cdk1-positive cells co-localize with p75 NTR (arrowhead), whereas many other p75 NTR -positive cells lack cdk1 immunolabeling (arrow). ( D ) Cdk1-positive cells co-localize with phosphoHistone H3 in the basal retina, close to the presumptive GCL (arrow). Arrowhead: apically located nucleus with cdk1-specific immunoreactivity. ( E ) TrkB-positive cells co-localize with cdk1 (arrow). Boxes: high magnification of the dashed areas. GCL: ganglion cell layer; PE: pigment epithelium; v: vitreous body. Bar: 20 µm ( A - D ), 40 µm ( E ).
3377s Ab 1549594 Phospho Chk1 Ser345 Cell Signaling Technology 2348l Ab 331212 Phospho Cdc2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3377s ab 1549594 phospho chk1 ser345 cell signaling technology 2348l ab 331212 phospho cdc2/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
3377s ab 1549594 phospho chk1 ser345 cell signaling technology 2348l ab 331212 phospho cdc2 - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier

Image Search Results


Decrease in phosphate in phosphoramidate phosphorylated histone H1 (▪) and 30 kDa polylysine (⧫) during incubation with PHPT1. The concentration was 1 mg/mL of phosphohistone and 2 mg/mL of phosphopolylysine. An amount of 5 pmol PHPT1 was added per 51 µL incubation volume. The reaction was performed at pH 7.5 and 30°C during indicated times and was interrupted by centrifugation of 50 µL of the reaction mixture through a spin column containing 200 µL of DEAE-Sepharose equilibrated in 25 mM Tris/HCl pH 8.5. The protein-bound, acid-labile phosphate in the final eluate was analyzed as described under Methods. Each time point was analyzed in duplicate.

Journal: Upsala Journal of Medical Sciences

Article Title: Phosphohistidine phosphatase 1 (PHPT1) also dephosphorylates phospholysine of chemically phosphorylated histone H1 and polylysine

doi: 10.3109/03009734.2014.996720

Figure Lengend Snippet: Decrease in phosphate in phosphoramidate phosphorylated histone H1 (▪) and 30 kDa polylysine (⧫) during incubation with PHPT1. The concentration was 1 mg/mL of phosphohistone and 2 mg/mL of phosphopolylysine. An amount of 5 pmol PHPT1 was added per 51 µL incubation volume. The reaction was performed at pH 7.5 and 30°C during indicated times and was interrupted by centrifugation of 50 µL of the reaction mixture through a spin column containing 200 µL of DEAE-Sepharose equilibrated in 25 mM Tris/HCl pH 8.5. The protein-bound, acid-labile phosphate in the final eluate was analyzed as described under Methods. Each time point was analyzed in duplicate.

Article Snippet: Chromatographically purified histone H1 from SignalChem was chemically phosphorylated as described above for the H1 preparation from Sigma-Aldrich, and then diluted with nine volumes of 0.1 M ammonium hydrogen carbonate and digested with 1 μg trypsin/100 μg histone for 3 h. The digestion was interrupted by freezing the sample at –20°C.

Techniques: Incubation, Concentration Assay, Centrifugation

Amino acid sequence and phosphorylated sites of bovine histone H1.2 as determined by mass spectrometry. Lysine residues are marked red, and those identified as targets for the phosphorylation by phosphoramidate (i.e. seven residues) are highlighted. Out of the 305 peptides that were used to identify the protein, 14 peptides were reported to contain phospholysine.

Journal: Upsala Journal of Medical Sciences

Article Title: Phosphohistidine phosphatase 1 (PHPT1) also dephosphorylates phospholysine of chemically phosphorylated histone H1 and polylysine

doi: 10.3109/03009734.2014.996720

Figure Lengend Snippet: Amino acid sequence and phosphorylated sites of bovine histone H1.2 as determined by mass spectrometry. Lysine residues are marked red, and those identified as targets for the phosphorylation by phosphoramidate (i.e. seven residues) are highlighted. Out of the 305 peptides that were used to identify the protein, 14 peptides were reported to contain phospholysine.

Article Snippet: Chromatographically purified histone H1 from SignalChem was chemically phosphorylated as described above for the H1 preparation from Sigma-Aldrich, and then diluted with nine volumes of 0.1 M ammonium hydrogen carbonate and digested with 1 μg trypsin/100 μg histone for 3 h. The digestion was interrupted by freezing the sample at –20°C.

Techniques: Sequencing, Mass Spectrometry, Phospho-proteomics

MS/MS spectrum showing the fragmentation pattern of one of the peptides obtained after trypsin treatment of histone H1 from SignalChem. The y-ion series is shown in red, and the b-ions series is in blue. Also shown is y- and b-ions fitting with the loss of 18 Da in violet and turquoise, respectively. Other observed but unspecified mached ions are grey. The small inset at the top shows only the y- and b-ions, with the length of the staples representing the intensity of the ions.

Journal: Upsala Journal of Medical Sciences

Article Title: Phosphohistidine phosphatase 1 (PHPT1) also dephosphorylates phospholysine of chemically phosphorylated histone H1 and polylysine

doi: 10.3109/03009734.2014.996720

Figure Lengend Snippet: MS/MS spectrum showing the fragmentation pattern of one of the peptides obtained after trypsin treatment of histone H1 from SignalChem. The y-ion series is shown in red, and the b-ions series is in blue. Also shown is y- and b-ions fitting with the loss of 18 Da in violet and turquoise, respectively. Other observed but unspecified mached ions are grey. The small inset at the top shows only the y- and b-ions, with the length of the staples representing the intensity of the ions.

Article Snippet: Chromatographically purified histone H1 from SignalChem was chemically phosphorylated as described above for the H1 preparation from Sigma-Aldrich, and then diluted with nine volumes of 0.1 M ammonium hydrogen carbonate and digested with 1 μg trypsin/100 μg histone for 3 h. The digestion was interrupted by freezing the sample at –20°C.

Techniques: Tandem Mass Spectroscopy

Fig. 5. NSs interacts with CDK1 and inhibits the cyclin B1-CDK1 complex from 744

Journal: Journal of Virology

Article Title: The Severe Fever with Thrombocytopenia Syndrome Virus NSs Protein Interacts with CDK1 To Induce G 2 Cell Cycle Arrest and Positively Regulate Viral Replication

doi: 10.1128/jvi.01575-19

Figure Lengend Snippet: Fig. 5. NSs interacts with CDK1 and inhibits the cyclin B1-CDK1 complex from 744

Article Snippet: Primary 426 antibodies to CDK1 (cat. no. 9611s) and Cyclin B1 (cat. no. 9915s) were 427 purchased from Cell Signaling Technology.

Techniques:

Fig. 6. The interaction between CDK1 and NSs is IB-dependent. (A) Schematic of 770

Journal: Journal of Virology

Article Title: The Severe Fever with Thrombocytopenia Syndrome Virus NSs Protein Interacts with CDK1 To Induce G 2 Cell Cycle Arrest and Positively Regulate Viral Replication

doi: 10.1128/jvi.01575-19

Figure Lengend Snippet: Fig. 6. The interaction between CDK1 and NSs is IB-dependent. (A) Schematic of 770

Article Snippet: Primary 426 antibodies to CDK1 (cat. no. 9611s) and Cyclin B1 (cat. no. 9915s) were 427 purchased from Cell Signaling Technology.

Techniques:

A, B. HeLa cells expressing GFP-CHMP7 δHelix6 were imaged live (A) and the intensity of GFP-CHMP7 δHelix6 puncta was quantified during M-phase (B). Quantification of 59 cells from 9 experiments. Fluorescence traces normalised to metaphase onset (open arrowhead); nuclear envelope breakdown indicated by closed arrowhead. C. Lysates of HeLa cells stably expressing GFP-CHMP7 and subject to the indicated synchronisations were immunoprecipitated using GFP-trap resin and resolved using normal or PhosTag SDS-PAGE. Inputs and captured fractions were examined by western blotting with antisera raised against GFP, or CDK1 substrate consensus sequences ([K/H]-[pS]-[P] or [pS]-[P]-[X]-[R/K]). Western blots representative of 6 PhosTag immunoprecipitations. D. Lysates of HeLa cells stably expressing GFP-CHMP7 or GFP-CHMP7 S3A, S441A and subject to the indicated synchronisations were immunoprecipitated using GFP-trap resin and resolved using normal or PhosTag SDS-PAGE. Inputs and captured fractions were examined by western blotting with antisera raised against GFP, Histone H3 pSer10 or GAPDH (N = 3).

Journal: bioRxiv

Article Title: CDK1 controls CHMP7-dependent nuclear envelope reformation

doi: 10.1101/2020.04.20.050674

Figure Lengend Snippet: A, B. HeLa cells expressing GFP-CHMP7 δHelix6 were imaged live (A) and the intensity of GFP-CHMP7 δHelix6 puncta was quantified during M-phase (B). Quantification of 59 cells from 9 experiments. Fluorescence traces normalised to metaphase onset (open arrowhead); nuclear envelope breakdown indicated by closed arrowhead. C. Lysates of HeLa cells stably expressing GFP-CHMP7 and subject to the indicated synchronisations were immunoprecipitated using GFP-trap resin and resolved using normal or PhosTag SDS-PAGE. Inputs and captured fractions were examined by western blotting with antisera raised against GFP, or CDK1 substrate consensus sequences ([K/H]-[pS]-[P] or [pS]-[P]-[X]-[R/K]). Western blots representative of 6 PhosTag immunoprecipitations. D. Lysates of HeLa cells stably expressing GFP-CHMP7 or GFP-CHMP7 S3A, S441A and subject to the indicated synchronisations were immunoprecipitated using GFP-trap resin and resolved using normal or PhosTag SDS-PAGE. Inputs and captured fractions were examined by western blotting with antisera raised against GFP, Histone H3 pSer10 or GAPDH (N = 3).

Article Snippet: Anti-CDK1 substrate antibodies were from Cell Signaling Technology (9477S and 2325S).

Techniques: Expressing, Fluorescence, Stable Transfection, Immunoprecipitation, SDS Page, Western Blot

A. 293T cells expressing the indicated GFP-CHMP7 constructs were cultured asynchronously or synchronised in prometaphase with STLC. GFP-tagged proteins were immunoprecipitated and examined by western blotting with antisera raised against GFP and the CDK1 substrate consensus sequence [K/H]-[pS]-[P]. N = 3. B. HeLa cells stably expressing GFP-CHMP7 393-CT or GFP-CHMP7 393-CT S441A were cultured asynchronously or synchronised prometaphase with STLC, then were lysed, resolved by normal or PhosTag SDS-PAGE and examined by western blotting with antisera raised against GFP, pSer10 Histone H3 or GAPDH (N = 3). C, D. 293T cells expressing the indicated GFP-CHMP7 NT proteins were cultured asynchronously or synchronised in prometaphase with STLC, then were lysed, resolved by normal or PhosTag SDS-PAGE and examined by western blotting with antisera raised against GFP or GAPDH (N = 3). In C, Ser/Thr containing mutants selected from a previously generated panel of alanine-scanning GFP-CHMP7 NT mutations were assessed for a mobility shift in mitosis. Mobility shift was compromised by M1, M27 and M28, although M27 and M28 were poorly expressed. M1 encodes the mutations W2A, S3A, P4A, E5A; M27 encodes the mutations R106A, E107A, S108A, D109A; M28 encodes the mutations F110A, M111A, A112G, S113A. Individual mutations of S3A, S108A and S113A from M1, M27 and M28 revealed the site of phosphorylation to be Ser 3 (D).

Journal: bioRxiv

Article Title: CDK1 controls CHMP7-dependent nuclear envelope reformation

doi: 10.1101/2020.04.20.050674

Figure Lengend Snippet: A. 293T cells expressing the indicated GFP-CHMP7 constructs were cultured asynchronously or synchronised in prometaphase with STLC. GFP-tagged proteins were immunoprecipitated and examined by western blotting with antisera raised against GFP and the CDK1 substrate consensus sequence [K/H]-[pS]-[P]. N = 3. B. HeLa cells stably expressing GFP-CHMP7 393-CT or GFP-CHMP7 393-CT S441A were cultured asynchronously or synchronised prometaphase with STLC, then were lysed, resolved by normal or PhosTag SDS-PAGE and examined by western blotting with antisera raised against GFP, pSer10 Histone H3 or GAPDH (N = 3). C, D. 293T cells expressing the indicated GFP-CHMP7 NT proteins were cultured asynchronously or synchronised in prometaphase with STLC, then were lysed, resolved by normal or PhosTag SDS-PAGE and examined by western blotting with antisera raised against GFP or GAPDH (N = 3). In C, Ser/Thr containing mutants selected from a previously generated panel of alanine-scanning GFP-CHMP7 NT mutations were assessed for a mobility shift in mitosis. Mobility shift was compromised by M1, M27 and M28, although M27 and M28 were poorly expressed. M1 encodes the mutations W2A, S3A, P4A, E5A; M27 encodes the mutations R106A, E107A, S108A, D109A; M28 encodes the mutations F110A, M111A, A112G, S113A. Individual mutations of S3A, S108A and S113A from M1, M27 and M28 revealed the site of phosphorylation to be Ser 3 (D).

Article Snippet: Anti-CDK1 substrate antibodies were from Cell Signaling Technology (9477S and 2325S).

Techniques: Expressing, Construct, Cell Culture, Immunoprecipitation, Western Blot, Sequencing, Stable Transfection, SDS Page, Generated, Mobility Shift, Phospho-proteomics

A. Recombinant CHMP7 was incubated with recombinant CDK1 and CCNB1 in the presence or absence of ATP and sedimented by ultracentrifugation. CHMP7 was recovered from pellet and supernatant fractions respectively, resolved by PhosTag SDS-PAGE and analysed by western blotting using antisera raised against CHMP7. B. Data from A presented as mean ± S.D., N = 4, *** P = 0.0007 by paired 2-tailed T-test. C. Recombinant CHMP7, CHMP7 S3D/S441D or CHMP7 S3E/S441E were sedimented by ultracentrifugation, recovered from pellet and supernatant fractions, and analysed by western blotting with antisera raised against CHMP7. D. Data from C presented as mean ± S.D., N = 8, *** P = 0.0004. E. Recombinant CHMP7 was incubated with recombinant CDK1 and CCNB1 in the presence or absence of ATP. Recombinant HA-LEM2 CT was added and CHMP7 was captured on magnetic anti-CHMP7 Dynabeads. Captured and input fractions were resolved by SDS-PAGE and examined by western blotting with anti-CHMP7 or anti-HA antisera. F. Data from G are presented as mean ± S.D., N = 7, P < 0.0001 by paired 2-tailed T-test. G. Recombinant HA-LEM2 CT was incubated alone, with CHMP7 or CHMP7 S3D/S441D. CHMP7 was captured on magnetic anti-CHMP7 Dynabeads. Captured and input fractions were resolved by SDS-PAGE and examined by western blotting with anti-CHMP7 or anti-HA antisera. Please note non-specific bands detected by CHMP7 antibody (*). H. Data from G are presented as mean ± S.D., N = 6, P < 0.0001 by paired 2-tailed T-test. I. Recombinant LEM2 CT , CHMP7 or CHMP7 S3D/S441D were examined by negative stain electron microscopy, either alone or in the combinations indicated. When incubated alone, no examples of polymerisation were observed. Images representative of N = 3 independent experiments. Scale bar is 25 nm.

Journal: bioRxiv

Article Title: CDK1 controls CHMP7-dependent nuclear envelope reformation

doi: 10.1101/2020.04.20.050674

Figure Lengend Snippet: A. Recombinant CHMP7 was incubated with recombinant CDK1 and CCNB1 in the presence or absence of ATP and sedimented by ultracentrifugation. CHMP7 was recovered from pellet and supernatant fractions respectively, resolved by PhosTag SDS-PAGE and analysed by western blotting using antisera raised against CHMP7. B. Data from A presented as mean ± S.D., N = 4, *** P = 0.0007 by paired 2-tailed T-test. C. Recombinant CHMP7, CHMP7 S3D/S441D or CHMP7 S3E/S441E were sedimented by ultracentrifugation, recovered from pellet and supernatant fractions, and analysed by western blotting with antisera raised against CHMP7. D. Data from C presented as mean ± S.D., N = 8, *** P = 0.0004. E. Recombinant CHMP7 was incubated with recombinant CDK1 and CCNB1 in the presence or absence of ATP. Recombinant HA-LEM2 CT was added and CHMP7 was captured on magnetic anti-CHMP7 Dynabeads. Captured and input fractions were resolved by SDS-PAGE and examined by western blotting with anti-CHMP7 or anti-HA antisera. F. Data from G are presented as mean ± S.D., N = 7, P < 0.0001 by paired 2-tailed T-test. G. Recombinant HA-LEM2 CT was incubated alone, with CHMP7 or CHMP7 S3D/S441D. CHMP7 was captured on magnetic anti-CHMP7 Dynabeads. Captured and input fractions were resolved by SDS-PAGE and examined by western blotting with anti-CHMP7 or anti-HA antisera. Please note non-specific bands detected by CHMP7 antibody (*). H. Data from G are presented as mean ± S.D., N = 6, P < 0.0001 by paired 2-tailed T-test. I. Recombinant LEM2 CT , CHMP7 or CHMP7 S3D/S441D were examined by negative stain electron microscopy, either alone or in the combinations indicated. When incubated alone, no examples of polymerisation were observed. Images representative of N = 3 independent experiments. Scale bar is 25 nm.

Article Snippet: Anti-CDK1 substrate antibodies were from Cell Signaling Technology (9477S and 2325S).

Techniques: Recombinant, Incubation, SDS Page, Western Blot, Staining, Electron Microscopy

A, B. CAL-51 cells homozygously edited to express mNG-CHMP7 (A) or HeLa cells stably expressing LEM2-mCh (B) were synchronised to prometaphase with STLC and then released through addition of RO-3306. Cells were imaged live through synchronised M-exit. C. Quantification of assembly onset (assembly duration presented in ) post RO3306 release. mNG-CHMP7 +/+ (onset 16.3 ± 0.88 mins; duration 3.1 ± 0.44 mins; N = 9, n = 104) or LEM2-mCh (onset 16.2 ± 2.22 mins; duration 4.1 ± 0.44 mins; N = 3, n = 80). Additional quantification of the above parameters from HeLa cells stably expressing GFP-CHMP7 (onset 16.9 ± 1.21 mins; duration 3.3 ± 0.13 mins; N = 3, n = 97) and subject to STLC arrest and RO3306 release (from ) and CAL-51 cells homozygously edited to express mNG-CHMP7 (onset 16.1 ± 2.02 mins; duration 4.2 ± 2.19 mins; N = 7, n = 39) and subject to nocodazole arrest and RO3306 release (from ) are also presented in C. A 1-way ANOVA with Tukey’s multiple comparisons revealed no significant differences between the datasets. D. E, HeLa cells stably expressing GFP-CHMP7 NT (D) or GFP-CHMP7 (E) were either untreated or arrested in mitosis through STLC inhibition and forced out of mitosis using RO3306 for the indicated times. Lysates in D, reporting Ser3 dephosphorylation were resolved by PhosTag or normal SDS-PAGE and examined with antisera raised against GFP or GAPDH respectively. Lysates from E, reporting Ser441 dephosphorylation were immunoprecipitated using GFP-trap resin and both inputs and captured fractions were examined by western blotting with antisera raised against phosphorylated CDK1 substrates and GFP (N = 3). F-H. CHMP7-depleted HeLa cells stably expressing GFP-CHMP7 R , GFP-CHMP7 R S3A/S441A or GFP-CHMP7 R S3D/S441D. were imaged live during mitotic exit (H). In F, the fold-enrichment of GFP-signal at the reforming nuclear envelope was calculated from 3 independent experiments, presented as mean (N = 3) ± S.E.M. (WT, n = 24; S3A/S441A, n = 27, n.s. (P = 0.92), S3D/S441D, n = 52, P = 0.049; 1-way ANOVA with Dunnett’s multiple comparisons). In G, the degree of furrow ingression (midzone diameter/daughter cell diameter) at the point of maximal GFP-CHMP7 recruitment was used as a proxy of progression through M-exit and was calculated from 3 independent experiments, presented as mean (N = 3) ± S.E.M. (WT, n = 24; S3A/S441A, n = 24, n.s. (P = 0.99), S3D/S441D, n = 46, P = 0.042; 1-way ANOVA with Dunnett’s multiple comparisons). In H, for cells stably expressing GFP-CHMP7 R S3A/S441A, arrowheads depict precocious clustering of CHMP7 in the peripheral ER during anaphase that develop into larger clusters during mitotic exit. In all panels, time in minutes and a scale bar of 10 μm are reported.

Journal: bioRxiv

Article Title: CDK1 controls CHMP7-dependent nuclear envelope reformation

doi: 10.1101/2020.04.20.050674

Figure Lengend Snippet: A, B. CAL-51 cells homozygously edited to express mNG-CHMP7 (A) or HeLa cells stably expressing LEM2-mCh (B) were synchronised to prometaphase with STLC and then released through addition of RO-3306. Cells were imaged live through synchronised M-exit. C. Quantification of assembly onset (assembly duration presented in ) post RO3306 release. mNG-CHMP7 +/+ (onset 16.3 ± 0.88 mins; duration 3.1 ± 0.44 mins; N = 9, n = 104) or LEM2-mCh (onset 16.2 ± 2.22 mins; duration 4.1 ± 0.44 mins; N = 3, n = 80). Additional quantification of the above parameters from HeLa cells stably expressing GFP-CHMP7 (onset 16.9 ± 1.21 mins; duration 3.3 ± 0.13 mins; N = 3, n = 97) and subject to STLC arrest and RO3306 release (from ) and CAL-51 cells homozygously edited to express mNG-CHMP7 (onset 16.1 ± 2.02 mins; duration 4.2 ± 2.19 mins; N = 7, n = 39) and subject to nocodazole arrest and RO3306 release (from ) are also presented in C. A 1-way ANOVA with Tukey’s multiple comparisons revealed no significant differences between the datasets. D. E, HeLa cells stably expressing GFP-CHMP7 NT (D) or GFP-CHMP7 (E) were either untreated or arrested in mitosis through STLC inhibition and forced out of mitosis using RO3306 for the indicated times. Lysates in D, reporting Ser3 dephosphorylation were resolved by PhosTag or normal SDS-PAGE and examined with antisera raised against GFP or GAPDH respectively. Lysates from E, reporting Ser441 dephosphorylation were immunoprecipitated using GFP-trap resin and both inputs and captured fractions were examined by western blotting with antisera raised against phosphorylated CDK1 substrates and GFP (N = 3). F-H. CHMP7-depleted HeLa cells stably expressing GFP-CHMP7 R , GFP-CHMP7 R S3A/S441A or GFP-CHMP7 R S3D/S441D. were imaged live during mitotic exit (H). In F, the fold-enrichment of GFP-signal at the reforming nuclear envelope was calculated from 3 independent experiments, presented as mean (N = 3) ± S.E.M. (WT, n = 24; S3A/S441A, n = 27, n.s. (P = 0.92), S3D/S441D, n = 52, P = 0.049; 1-way ANOVA with Dunnett’s multiple comparisons). In G, the degree of furrow ingression (midzone diameter/daughter cell diameter) at the point of maximal GFP-CHMP7 recruitment was used as a proxy of progression through M-exit and was calculated from 3 independent experiments, presented as mean (N = 3) ± S.E.M. (WT, n = 24; S3A/S441A, n = 24, n.s. (P = 0.99), S3D/S441D, n = 46, P = 0.042; 1-way ANOVA with Dunnett’s multiple comparisons). In H, for cells stably expressing GFP-CHMP7 R S3A/S441A, arrowheads depict precocious clustering of CHMP7 in the peripheral ER during anaphase that develop into larger clusters during mitotic exit. In all panels, time in minutes and a scale bar of 10 μm are reported.

Article Snippet: Anti-CDK1 substrate antibodies were from Cell Signaling Technology (9477S and 2325S).

Techniques: Stable Transfection, Expressing, Inhibition, De-Phosphorylation Assay, SDS Page, Immunoprecipitation, Western Blot

A FMNL1 schematic ( B ) MSMS scan of residues 1024–1034 (1 experiment). C Representative GFP-FMNL1 IP from cells treated with vehicle ( ~ 2 h DMSO) or adavosertib ( ~ 6.5 h 300 nM). Probed with anti-GFP and anti-phoso-CDK1 substrate sequence. Repeated 3X. D Effects of ~4 h adavosertib at 300 nM on wave. Unequal contrasting between groups for ease of viewing. E Effects of CDK1 inhibitors on wave. Asterisk denotes contrast adjustment between conditions, performed as acquisition parameters varied throughout experiment. F CDK1 siRNA treatment. G Effects of adavosertib on wave speed; bars represent means with SEM. Two-sided Student’s t-test. N = 20 and 23 cells across 4 experiments for DMSO and Wee1 inhibitor, respectively. H Effects of CDK1 inhibitors on wave area. CDK1 inhibitors tested in a larger screen; DMSO data run in parallel previously published in Extended figure 8 A of ref. . Analyzed by Kruskal-Wallis test with Dunn’s multiple comparisons was run. n = 151 and 212 cells across 3 experiments for Ro3306 and CGP74 conditions, respectively. I Effects of CDK1 knockdown on wave area. Kruskal-Wallis test with Dunn’s multiple comparisons. n = 60 cells across 3 experiments. J CDK1 knockdown (see Figure ). Means from 3 experiments. K Effects of GFP-FMNL1 WT and S1031A on wave; staining TOMM20 and phalloidin. GFP signal for ‘GFP alone’ condition was differentially scaled. L Wave areas analyzed by Kruskal-Wallis test, Dunn’s multiple comparisons; 40 cells across 4 experiments. M Western blot of GFP-FMNL1 WT and S1031A. N Mean fluorescence: GFP-FMNL1 WT/S1031A. Bars indicate means of triangles, which represent means of 4 biological replicates. O Effects of S1031E on wave; staining for TOMM20 and phalloidin. P Effects on wave area; two-sided Mann-Whitney test, 60 cells across 3 experiments. Q Western of GFP-FMNL1 S1031E. R Mean fluorescence: GFP-FMNL1 WT/S1031E. A – R Scale bars: 10 μm for cell images, 2 μm for insets. For blots, antibody/total protein approximately aligned/scaled the same; kDa, unit of molecular weight. Box plots: center lines indicate medians, plus signs indicate means, error bars = 10–90th percentile. Source data provided. *, **, and *** indicate p -values of < 0.05, ≤ 0.005, and ≤ 0.0005 respectively.

Journal: Nature Communications

Article Title: An interphase actin wave promotes mitochondrial content mixing and organelle homeostasis

doi: 10.1038/s41467-024-48189-1

Figure Lengend Snippet: A FMNL1 schematic ( B ) MSMS scan of residues 1024–1034 (1 experiment). C Representative GFP-FMNL1 IP from cells treated with vehicle ( ~ 2 h DMSO) or adavosertib ( ~ 6.5 h 300 nM). Probed with anti-GFP and anti-phoso-CDK1 substrate sequence. Repeated 3X. D Effects of ~4 h adavosertib at 300 nM on wave. Unequal contrasting between groups for ease of viewing. E Effects of CDK1 inhibitors on wave. Asterisk denotes contrast adjustment between conditions, performed as acquisition parameters varied throughout experiment. F CDK1 siRNA treatment. G Effects of adavosertib on wave speed; bars represent means with SEM. Two-sided Student’s t-test. N = 20 and 23 cells across 4 experiments for DMSO and Wee1 inhibitor, respectively. H Effects of CDK1 inhibitors on wave area. CDK1 inhibitors tested in a larger screen; DMSO data run in parallel previously published in Extended figure 8 A of ref. . Analyzed by Kruskal-Wallis test with Dunn’s multiple comparisons was run. n = 151 and 212 cells across 3 experiments for Ro3306 and CGP74 conditions, respectively. I Effects of CDK1 knockdown on wave area. Kruskal-Wallis test with Dunn’s multiple comparisons. n = 60 cells across 3 experiments. J CDK1 knockdown (see Figure ). Means from 3 experiments. K Effects of GFP-FMNL1 WT and S1031A on wave; staining TOMM20 and phalloidin. GFP signal for ‘GFP alone’ condition was differentially scaled. L Wave areas analyzed by Kruskal-Wallis test, Dunn’s multiple comparisons; 40 cells across 4 experiments. M Western blot of GFP-FMNL1 WT and S1031A. N Mean fluorescence: GFP-FMNL1 WT/S1031A. Bars indicate means of triangles, which represent means of 4 biological replicates. O Effects of S1031E on wave; staining for TOMM20 and phalloidin. P Effects on wave area; two-sided Mann-Whitney test, 60 cells across 3 experiments. Q Western of GFP-FMNL1 S1031E. R Mean fluorescence: GFP-FMNL1 WT/S1031E. A – R Scale bars: 10 μm for cell images, 2 μm for insets. For blots, antibody/total protein approximately aligned/scaled the same; kDa, unit of molecular weight. Box plots: center lines indicate medians, plus signs indicate means, error bars = 10–90th percentile. Source data provided. *, **, and *** indicate p -values of < 0.05, ≤ 0.005, and ≤ 0.0005 respectively.

Article Snippet: For western blots and immunofluorescence the following primary antibodies were used: TOMM20 (Santa Cruz, sc-17764), FMNL1 (Abcam, ab97456), FMNL2 (Santa Cruz, sc-390298), GFP (abcam, ab1218), GFP (Aves, 1020), phospho-CDK1 substrate consensus sequence (CST, 2325), CDK1 (abcam, ab131450), ARP3 (Proteintech, 13822-1-AP), WHAMM (abcam, ab122572).

Techniques: Sequencing, Knockdown, Staining, Western Blot, Fluorescence, MANN-WHITNEY, Molecular Weight

Confocal sections from retinas of E6 chick embryos were double labeled with the anti-cdk1 specific mAbs (red) (B-6) ( A ), [A17] ( B ), and (17) ( C - E ), as well as with anti-p75 NTR (p75) ( C ), anti-phosphoHistone H3 (pH3) ( D ), or anti-TrkB ( E ) antibodies (green). Nuclear staining with bisbenzimide is shown in blue (Bisb.). ( A , B ) Cdk1 immunostaining is observed in the cytoplasm of a subpopulation of retinal cells and often in nuclei located apically (arrows). ( C ) A subset of cdk1-positive cells co-localize with p75 NTR (arrowhead), whereas many other p75 NTR -positive cells lack cdk1 immunolabeling (arrow). ( D ) Cdk1-positive cells co-localize with phosphoHistone H3 in the basal retina, close to the presumptive GCL (arrow). Arrowhead: apically located nucleus with cdk1-specific immunoreactivity. ( E ) TrkB-positive cells co-localize with cdk1 (arrow). Boxes: high magnification of the dashed areas. GCL: ganglion cell layer; PE: pigment epithelium; v: vitreous body. Bar: 20 µm ( A - D ), 40 µm ( E ).

Journal: PLoS ONE

Article Title: Brain-Derived Neurotrophic Factor-Dependent cdk1 Inhibition Prevents G2/M Progression in Differentiating Tetraploid Neurons

doi: 10.1371/journal.pone.0064890

Figure Lengend Snippet: Confocal sections from retinas of E6 chick embryos were double labeled with the anti-cdk1 specific mAbs (red) (B-6) ( A ), [A17] ( B ), and (17) ( C - E ), as well as with anti-p75 NTR (p75) ( C ), anti-phosphoHistone H3 (pH3) ( D ), or anti-TrkB ( E ) antibodies (green). Nuclear staining with bisbenzimide is shown in blue (Bisb.). ( A , B ) Cdk1 immunostaining is observed in the cytoplasm of a subpopulation of retinal cells and often in nuclei located apically (arrows). ( C ) A subset of cdk1-positive cells co-localize with p75 NTR (arrowhead), whereas many other p75 NTR -positive cells lack cdk1 immunolabeling (arrow). ( D ) Cdk1-positive cells co-localize with phosphoHistone H3 in the basal retina, close to the presumptive GCL (arrow). Arrowhead: apically located nucleus with cdk1-specific immunoreactivity. ( E ) TrkB-positive cells co-localize with cdk1 (arrow). Boxes: high magnification of the dashed areas. GCL: ganglion cell layer; PE: pigment epithelium; v: vitreous body. Bar: 20 µm ( A - D ), 40 µm ( E ).

Article Snippet: The rabbit anti-phospho-Rb (Ser780) antibody (HTScan CDK1/CycB Kinase Assay Kit; Cell Signaling Technology) was used at 1/1,000 dilution for sandwich ELISA.

Techniques: Labeling, Staining, Immunostaining, Immunolabeling

( A ) Lysates from DCRNs cultured for 20 h in the presence of different combinations of 100 ng/m NGF and 2 ng/ml BDNF were subjected to western blot with antibodies specific for either cdk1 (upper panel) or β-actin (lower panel). ( B ) Normalized cdk1/β-actin ratio. ( C ) Semiquantitative RT-PCR analysis of mRNA samples obtained from DCRNs cultured for 20 h in the presence of either vehicle (Control) or 2 ng/ml BDNF (BDNF). The levels of Cdk1 expression were normalized to Gapdh . N.S. non-significant; *p<0.05 (Student’s t test; n = 3–4).

Journal: PLoS ONE

Article Title: Brain-Derived Neurotrophic Factor-Dependent cdk1 Inhibition Prevents G2/M Progression in Differentiating Tetraploid Neurons

doi: 10.1371/journal.pone.0064890

Figure Lengend Snippet: ( A ) Lysates from DCRNs cultured for 20 h in the presence of different combinations of 100 ng/m NGF and 2 ng/ml BDNF were subjected to western blot with antibodies specific for either cdk1 (upper panel) or β-actin (lower panel). ( B ) Normalized cdk1/β-actin ratio. ( C ) Semiquantitative RT-PCR analysis of mRNA samples obtained from DCRNs cultured for 20 h in the presence of either vehicle (Control) or 2 ng/ml BDNF (BDNF). The levels of Cdk1 expression were normalized to Gapdh . N.S. non-significant; *p<0.05 (Student’s t test; n = 3–4).

Article Snippet: The rabbit anti-phospho-Rb (Ser780) antibody (HTScan CDK1/CycB Kinase Assay Kit; Cell Signaling Technology) was used at 1/1,000 dilution for sandwich ELISA.

Techniques: Cell Culture, Western Blot, Reverse Transcription Polymerase Chain Reaction, Expressing

( A ) General cdk protein kinase activity, based on the phosphorylation of a Rb-derived peptide by the cdk activity present in cell extracts from DCRNs cultured for 20 h in the presence of 100 ng/ml NGF and treated for 30 min with either vehicle (Control) or 2 ng/ml BDNF. Equal amount of cell extracts were used in both cases. ( B ) Left panel, a representative western blot performed with an anti-cdk1 antibody using the cell extracts described above prior to immunoprecipitation (INPUT). Right panel, protein kinase activity immunoprecipitated with an anti cdk1 antibody (i.e. cdk1-specific kinase activity) from the cell extracts described above, normalized to the relative amount of cdk1 present in these extracts (see input in left panel). *p<0.05 (ANOVA; n = 3).

Journal: PLoS ONE

Article Title: Brain-Derived Neurotrophic Factor-Dependent cdk1 Inhibition Prevents G2/M Progression in Differentiating Tetraploid Neurons

doi: 10.1371/journal.pone.0064890

Figure Lengend Snippet: ( A ) General cdk protein kinase activity, based on the phosphorylation of a Rb-derived peptide by the cdk activity present in cell extracts from DCRNs cultured for 20 h in the presence of 100 ng/ml NGF and treated for 30 min with either vehicle (Control) or 2 ng/ml BDNF. Equal amount of cell extracts were used in both cases. ( B ) Left panel, a representative western blot performed with an anti-cdk1 antibody using the cell extracts described above prior to immunoprecipitation (INPUT). Right panel, protein kinase activity immunoprecipitated with an anti cdk1 antibody (i.e. cdk1-specific kinase activity) from the cell extracts described above, normalized to the relative amount of cdk1 present in these extracts (see input in left panel). *p<0.05 (ANOVA; n = 3).

Article Snippet: The rabbit anti-phospho-Rb (Ser780) antibody (HTScan CDK1/CycB Kinase Assay Kit; Cell Signaling Technology) was used at 1/1,000 dilution for sandwich ELISA.

Techniques: Activity Assay, Derivative Assay, Cell Culture, Western Blot, Immunoprecipitation

( A ) E6 retinal cells electroporated with either EGFP (-) or cdk1 plus cyclin B1 (CC) and EGFP (+) were cultured under neurogenic conditions for 20 h in the presence of different combinations of 100 ng/ml NGF and 2 ng/ml BDNF. The percentage of mitotic figures was evaluated in the EGFP-positive cells. Lower panels show an example of a mitotic figure (pH3; red) in an EGFP-transfected cell (EGFP) (arrow). ( B ) E6 retinal cells were electroporated and cultured as above. The percentage of pyknotic nuclei was evaluated in the EGFP-positive cells. Lower panels show an example of a pyknotic nucleus in an EGFP-transfected cell (EGFP) (arrow). Bisb.: bisbenzimide. *p<0.05; ***p<0.005 (Student’s t test; n = 4). Bars: 10 µm.

Journal: PLoS ONE

Article Title: Brain-Derived Neurotrophic Factor-Dependent cdk1 Inhibition Prevents G2/M Progression in Differentiating Tetraploid Neurons

doi: 10.1371/journal.pone.0064890

Figure Lengend Snippet: ( A ) E6 retinal cells electroporated with either EGFP (-) or cdk1 plus cyclin B1 (CC) and EGFP (+) were cultured under neurogenic conditions for 20 h in the presence of different combinations of 100 ng/ml NGF and 2 ng/ml BDNF. The percentage of mitotic figures was evaluated in the EGFP-positive cells. Lower panels show an example of a mitotic figure (pH3; red) in an EGFP-transfected cell (EGFP) (arrow). ( B ) E6 retinal cells were electroporated and cultured as above. The percentage of pyknotic nuclei was evaluated in the EGFP-positive cells. Lower panels show an example of a pyknotic nucleus in an EGFP-transfected cell (EGFP) (arrow). Bisb.: bisbenzimide. *p<0.05; ***p<0.005 (Student’s t test; n = 4). Bars: 10 µm.

Article Snippet: The rabbit anti-phospho-Rb (Ser780) antibody (HTScan CDK1/CycB Kinase Assay Kit; Cell Signaling Technology) was used at 1/1,000 dilution for sandwich ELISA.

Techniques: Cell Culture, Transfection

( A ) Validation of the cdk1 sandwich ELISA assay performed with 10 fg of either GST (GST) or a chimeric protein containing the sequence of human cdk1 bound to GST (Cdk1-GST), and revealed with the anti-cdk1 PSTAIRE antibody. Normalized optical density (O.D.) at 405 nm is shown. ( B ) Validation of the phospho-cdk1 sandwich ELISA assay performed with cell lysates obtained from DCRNs cultured in the presence of 100 ng/ml NGF and 2 ng/ml BDNF, incubated either in the absence (- CIP) or presence (+ CIP) of CIP, and revealed with the anti-cdk1 (pTyr15) antibody. Normalized optical density (O.D.) at 405 nm is shown. ( C ) Cell lysates from DCRNs cultured in the presence (+) or absence (-) of the referred factors were subjected to sandwich ELISA analyses using antibodies specific for either cdk1 phosphorylated at Tyr15 or total cdk1 protein. Colorimetric values for cdk1 phosphorylated at Tyr15 were normalized to the levels of cdk1 protein (Cdk1). ( D ) Cell lysates from DCRNs cultured in the presence of the referred factors and/or K252a were subjected to sandwich ELISA analyses as described above. Colorimetric values for cdk1 phosphorylated at Tyr15 were normalized to the levels of cdk1 protein (Cdk1). *p<0.05; ***p<0.005 (Student’s t test; n = 3).

Journal: PLoS ONE

Article Title: Brain-Derived Neurotrophic Factor-Dependent cdk1 Inhibition Prevents G2/M Progression in Differentiating Tetraploid Neurons

doi: 10.1371/journal.pone.0064890

Figure Lengend Snippet: ( A ) Validation of the cdk1 sandwich ELISA assay performed with 10 fg of either GST (GST) or a chimeric protein containing the sequence of human cdk1 bound to GST (Cdk1-GST), and revealed with the anti-cdk1 PSTAIRE antibody. Normalized optical density (O.D.) at 405 nm is shown. ( B ) Validation of the phospho-cdk1 sandwich ELISA assay performed with cell lysates obtained from DCRNs cultured in the presence of 100 ng/ml NGF and 2 ng/ml BDNF, incubated either in the absence (- CIP) or presence (+ CIP) of CIP, and revealed with the anti-cdk1 (pTyr15) antibody. Normalized optical density (O.D.) at 405 nm is shown. ( C ) Cell lysates from DCRNs cultured in the presence (+) or absence (-) of the referred factors were subjected to sandwich ELISA analyses using antibodies specific for either cdk1 phosphorylated at Tyr15 or total cdk1 protein. Colorimetric values for cdk1 phosphorylated at Tyr15 were normalized to the levels of cdk1 protein (Cdk1). ( D ) Cell lysates from DCRNs cultured in the presence of the referred factors and/or K252a were subjected to sandwich ELISA analyses as described above. Colorimetric values for cdk1 phosphorylated at Tyr15 were normalized to the levels of cdk1 protein (Cdk1). *p<0.05; ***p<0.005 (Student’s t test; n = 3).

Article Snippet: The rabbit anti-phospho-Rb (Ser780) antibody (HTScan CDK1/CycB Kinase Assay Kit; Cell Signaling Technology) was used at 1/1,000 dilution for sandwich ELISA.

Techniques: Sandwich ELISA, Sequencing, Cell Culture, Incubation

( A ) Cell lysates from DCRNs cultured in the presence of the referred factors and/or 300 nM MK-1775 were subjected to sandwich ELISA analyses using antibodies specific for either cdk1 phosphorylated at Tyr15 or total cdk1 protein. Colorimetric values for cdk1 phosphorylated at Tyr15 were normalized to the levels of cdk1 protein (Cdk1). ( B ) Cell lysates from CEFs cultured in the presence (+) or absence (-) of 300 nM MK-1775 were subjected to sandwich ELISA analyses as described above. Colorimetric values for cdk1 phosphorylated at Tyr15 were normalized to the levels of cdk1 protein (Cdk1). ***p<0.005 (Student’s t test; n = 3). # p<0.05 (NGF/BDNF/MK-1775 vs NGF/MK-1775; Student’s t test; n = 3).

Journal: PLoS ONE

Article Title: Brain-Derived Neurotrophic Factor-Dependent cdk1 Inhibition Prevents G2/M Progression in Differentiating Tetraploid Neurons

doi: 10.1371/journal.pone.0064890

Figure Lengend Snippet: ( A ) Cell lysates from DCRNs cultured in the presence of the referred factors and/or 300 nM MK-1775 were subjected to sandwich ELISA analyses using antibodies specific for either cdk1 phosphorylated at Tyr15 or total cdk1 protein. Colorimetric values for cdk1 phosphorylated at Tyr15 were normalized to the levels of cdk1 protein (Cdk1). ( B ) Cell lysates from CEFs cultured in the presence (+) or absence (-) of 300 nM MK-1775 were subjected to sandwich ELISA analyses as described above. Colorimetric values for cdk1 phosphorylated at Tyr15 were normalized to the levels of cdk1 protein (Cdk1). ***p<0.005 (Student’s t test; n = 3). # p<0.05 (NGF/BDNF/MK-1775 vs NGF/MK-1775; Student’s t test; n = 3).

Article Snippet: The rabbit anti-phospho-Rb (Ser780) antibody (HTScan CDK1/CycB Kinase Assay Kit; Cell Signaling Technology) was used at 1/1,000 dilution for sandwich ELISA.

Techniques: Cell Culture, Sandwich ELISA

E6 retinal cells electroporated with either EGFP (-) or the Tyr15Phe mutant form of cdk1 plus cyclin B1 (Mut CC) and EGFP (+) were cultured for 20 h under neurogenic conditions in the presence of different combinations of 100 ng/ml NGF and 2 ng/m BDNF. The percentage of pyknotic nuclei was evaluated in EGFP-positive cells. *p<0.05 (Student’s t test; n = 4).

Journal: PLoS ONE

Article Title: Brain-Derived Neurotrophic Factor-Dependent cdk1 Inhibition Prevents G2/M Progression in Differentiating Tetraploid Neurons

doi: 10.1371/journal.pone.0064890

Figure Lengend Snippet: E6 retinal cells electroporated with either EGFP (-) or the Tyr15Phe mutant form of cdk1 plus cyclin B1 (Mut CC) and EGFP (+) were cultured for 20 h under neurogenic conditions in the presence of different combinations of 100 ng/ml NGF and 2 ng/m BDNF. The percentage of pyknotic nuclei was evaluated in EGFP-positive cells. *p<0.05 (Student’s t test; n = 4).

Article Snippet: The rabbit anti-phospho-Rb (Ser780) antibody (HTScan CDK1/CycB Kinase Assay Kit; Cell Signaling Technology) was used at 1/1,000 dilution for sandwich ELISA.

Techniques: Mutagenesis, Cell Culture

TrkB activation by BDNF prevents the increase cyclin B and cdk1 protein expression (dashed line) and induces phosphorylation of cdk1 at Tyr15 (thick black arrow), thus inhibiting cdk1 kinase activity. This effect participates in the G2/M arrest (grey line) observed in tetraploid RGCs.

Journal: PLoS ONE

Article Title: Brain-Derived Neurotrophic Factor-Dependent cdk1 Inhibition Prevents G2/M Progression in Differentiating Tetraploid Neurons

doi: 10.1371/journal.pone.0064890

Figure Lengend Snippet: TrkB activation by BDNF prevents the increase cyclin B and cdk1 protein expression (dashed line) and induces phosphorylation of cdk1 at Tyr15 (thick black arrow), thus inhibiting cdk1 kinase activity. This effect participates in the G2/M arrest (grey line) observed in tetraploid RGCs.

Article Snippet: The rabbit anti-phospho-Rb (Ser780) antibody (HTScan CDK1/CycB Kinase Assay Kit; Cell Signaling Technology) was used at 1/1,000 dilution for sandwich ELISA.

Techniques: Activation Assay, Expressing, Activity Assay